This bill mandates the Agency for Health Care Administration to seek federal approval within 30 days of the act becoming law to provide Medicaid coverage for continuous glucose monitors and related supplies as durable medical equipment. It specifies that licensed durable medical equipment providers must be reimbursed for these monitors, with claims submitted through the Medicare Healthcare Common Procedure Coding System, and it prohibits the agency from requiring the use of a National Drug Code number for claim submissions. Additionally, the bill clarifies that the agency can offer further coverage of continuous glucose monitors as a Medicaid pharmacy benefit.

The agency is required to implement these changes once federal approval is obtained. The act is set to take effect immediately upon becoming law.